Intravenous Treprostinil in Severe Inoperable Chronic Thromboembolic Pulmonary Hypertension Using Implantable Pumps—Single-Center Experience over More Than a Decade

Intravenous Treprostinil in Severe Inoperable Chronic Thromboembolic Pulmonary Hypertension Using Implantable Pumps—Single-Center Experience over More Than a Decade

The management of chronic thromboembolic pulmonary hypertension has significantly changed over the last decade with the availability of both specific therapies and interventional treatments. In parallel, implantable pumps for intravenous administration of treprostinil have broadened the spectrum of...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Regina Steringer-Mascherbauer, Charlotte Huber, Uwe Fröschl, Dagmar Engleder, Reinhold Függer, Maria Lummersdorfer, Ralf Lenhard, Martin Martinek
التنسيق:	مقال
اللغة:	English
منشور في:	MDPI AG 2023-07-01
سلاسل:	Journal of Cardiovascular Development and Disease
الموضوعات:	chronic thromboembolic pulmonary hypertension implantable pump intravenous treprostinil
الوصول للمادة أونلاين:	https://www.mdpi.com/2308-3425/10/8/318

مواد مشابهة

The risk profile change in patients with severe chronic thromboembolic pulmonary hypertension treated with subcutaneous treprostinil
حسب: Pavel Jansa, وآخرون
منشور في: (2023-07-01)

Long-term experience with implantable infusion pumps for intravenous treprostinil in pulmonary arterial hypertension—procedural safety and system-related complications
حسب: Regina Steringer-Mascherbauer, وآخرون
منشور في: (2020-11-01)

Combination therapy with riociquat and inhaled treprostinil in inoperable and progressive chronic thromboembolic pulmonary hypertension
حسب: John W. Swisher, PhD, MD, وآخرون
منشور في: (2017-01-01)

Periprocedural safety and outcome after pump implantation for intravenous treprostinil administration in patients with pulmonary arterial hypertension
حسب: Jan C. Kamp, وآخرون
منشور في: (2021-05-01)

An implantable pump Lenus pro® in the treatment of pulmonary arterial hypertension with intravenous treprostinil
حسب: Marcin Kurzyna, وآخرون
منشور في: (2017-12-01)

Venoarterial extracorporeal membrane oxygenation for vasoplegic shock after treprostinil refill of an implanted intravenous pump: a case report
حسب: Lucía Valencia, وآخرون
منشور في: (2024-01-01)

The effects of standardized intravenous treprostinil in pulmonary arterial hypertension patients after total cavo-pulmonary connection procedure
حسب: Xiaofeng Wang, وآخرون
منشور في: (2024-10-01)

Failure to tolerate continuous subcutaneous treprostinil in pediatric pulmonary hypertension patients
حسب: Julia McSweeney, وآخرون
منشور في: (2023-04-01)

Efficacy of oral treprostinil for treating pulmonary arterial hypertension: a systematic review and meta-analysis
حسب: Lianghua Xiao, وآخرون
منشور في: (2024-09-01)

Design, Development, and Evaluation of Treprostinil Embedded Adhesive Transdermal Patch
حسب: Ibrahim Alissa, وآخرون
منشور في: (2023-04-01)

Prenatal treprostinil reduces the pulmonary hypertension phenotype in the rat model of congenital diaphragmatic hernia
حسب: Felix Rafael De Bie, وآخرون
منشور في: (2022-07-01)

The Importance of Dose Escalation in the Treatment of Pulmonary Arterial Hypertension with Treprostinil
حسب: Piotr Kędzierski, وآخرون
منشور في: (2025-01-01)

Comparison of treprostinil and oral sildenafil for the treatment of persistent pulmonary hypertension of the newborn: a retrospective cohort study
حسب: Enhuan Wei, وآخرون
منشور في: (2023-11-01)

Peak steps to measure ‘‘capacity for activity’’: Actigraphy in the ADAPT registry with oral treprostinil
حسب: Daniel Lachant, DO, وآخرون
منشور في: (2025-05-01)

INSPIRE: Safety and tolerability of inhaled Yutrepia (treprostinil) in pulmonary arterial hypertension (PAH)
حسب: Nicholas S. Hill, وآخرون
منشور في: (2022-07-01)

Pulmonary Hypertension-Associated Right Ventricular Cardiomyocyte Remodelling Reduces Treprostinil Function
حسب: Aleksandra Judina, وآخرون
منشور في: (2023-12-01)

Evaluation of patients with severe pulmonary hypertension and a range of comorbidities prescribed inhaled treprostinil
حسب: Aparna C. Swaminathan, وآخرون
منشور في: (2024-11-01)

BREEZE: Open‐label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™ in patients with pulmonary arterial hypertension
حسب: Leslie A. Spikes, وآخرون
منشور في: (2022-04-01)

Evaluation and Selection of the Inhaler Device for Treprostinil Palmitil Inhalation Powder
حسب: Helena Gauani, وآخرون
منشور في: (2022-04-01)

Cannabidiol (CBD) for the treatment of subcutaneous treprostinil (Remodulin®) site pain: a case report
حسب: Jacqueline Brewer, وآخرون
منشور في: (2023-06-01)

Real‐world use of inhaled treprostinil for lung disease‐pulmonary hypertension: A protocol for patient evaluation and prescribing
حسب: Shelsey W. Johnson, وآخرون
منشور في: (2022-07-01)

Unexpected Acceleration in Treprostinil Delivery Administered by a Lenus Pro® Implantable Pump in Two Patients Treated for Pulmonary Arterial Hypertension
حسب: Garance Kopp, وآخرون
منشور في: (2020-10-01)

Effect of Inhalation Profile on Delivery of Treprostinil Palmitil Inhalation Powder
حسب: Helena Gauani, وآخرون
منشور في: (2023-03-01)

Severe bronchospasm and acute respiratory failure associated with inhaled prostacyclin therapy
حسب: Donna Steinbacher, وآخرون
منشور في: (2024-04-01)

Renal infarction associated with low dose intravenous immunoglobulin in a kidney transplant recipient with sepsis: a case report and literature review
حسب: Eun Woo Choi, وآخرون
منشور في: (2021-10-01)

Treatment Strategy Options in Inoperable Chronic Thromboembolic Pulmonary Hypertension Patients
حسب: N. V. Marukyan, وآخرون
منشور في: (2021-05-01)

Balloon pulmonary angioplasty for patients with inoperable chronic thromboembolic pulmonary hypertension
حسب: N M Danilov, وآخرون
منشور في: (2019-04-01)

Oral Prostacyclin Pathway Agents Used in PAH: A Targeted Literature Review
حسب: Burger CD, وآخرون
منشور في: (2024-05-01)

Direct prostacyclin transition in pediatric patients with pulmonary hypertension
حسب: Kelly Merrill, وآخرون
منشور في: (2024-04-01)

Bilateral versus unilateral balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension
حسب: Cheng Hong, وآخرون
منشور في: (2022-05-01)

Efficacy and safety of balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension
حسب: Zheng-Wei Chen, وآخرون
منشور في: (2021-03-01)

Cation exchange chromatography removes FXIa from a 10% intravenous immunoglobulin preparation
حسب: Gil Bu Kang, وآخرون
منشور في: (2023-11-01)

Inoperable chronic thromboembolic pulmonary hypertension: Evolution of prognosis over 10 years of new emerging therapies
حسب: Diederik P. Staal, وآخرون
منشور في: (2024-07-01)

Sex-specific cardiopulmonary exercise testing indices to estimate the severity of inoperable chronic thromboembolic pulmonary hypertension
حسب: Chen TX, وآخرون
منشور في: (2018-01-01)

Improved hemodynamics and cardiopulmonary function in patients with inoperable chronic thromboembolic pulmonary hypertension after balloon pulmonary angioplasty
حسب: Qi Jin, وآخرون
منشور في: (2019-11-01)

Chronic Thromboembolic Pulmonary Hypertension and ChronicThromboembolic Pulmonary Disease
حسب: HUANG Shenshen, وآخرون
منشور في: (2023-01-01)

Congruency between clinician‐assessed risk and calculated risk of 1‐year mortality in patients with pulmonary arterial hypertension: A retrospective chart review
حسب: Amresh Raina, وآخرون
منشور في: (2024-10-01)

Corrigendum: Case report: Selexipag in pediatric pulmonary hypertension: initiation, transition, and titration
حسب: Jenna M. Faircloth, وآخرون
منشور في: (2023-08-01)

Case Report: Selexipag in pediatric pulmonary hypertension: Initiation, transition, and titration
حسب: Jenna M. Faircloth, وآخرون
منشور في: (2023-03-01)

Perioperative thromboembolism prophylaxis in children – is it necessary?
حسب: Izabela Pągowska-Klimek
منشور في: (2020-08-01)